by In2Pharma | Aug 8, 2024 | News
The Netherlands Disclosure of financial interactions between pharmaceutical companies and healthcare professionals and organisations, and patient organisations can be reported in the Transparency Register Zorg in the Netherlands (www.transparantieregister.nl)....
by In2Pharma | Jul 11, 2024 | News
The Netherlands Online advertising for self-care products by influencers is increasing significantly, raising concerns about control and misinformation. Influencer registry A registry of certified influencers was opened in April. These influencers annually complete an...
by In2Pharma | May 8, 2024 | News
The Netherlands GMH organizes multiple trainings on the regulation of premiums and benefits with regard to medical devices. They offer two levels of training: a basic training and a more advanced training. These trainings will take up one half of a day (before noon)...
by In2Pharma | Jan 11, 2023 | News
The Netherlands Marketing authorization holders who want to temporarily supply a medicine in a different packaging in the event of a medicine shortage will need permission from the MEB from 1 January 2023. The MEB will take over this task from the Healthcare and Youth...
by In2Pharma | Dec 12, 2022 | News
The Netherlands Drug shortages are an important issue since the COVID-19 pandemic. According to the Medicines Act, each Marketing Authorisation Holder (MAH) and Wholesaler must ensure that sufficient supply of each medicine is available. The interpretation of...
